To submit and contribute drug or therapy review information, input, and/or feedback online, you must be registered for one of the following CADTH Optimal Use CAR T-Cell Therapy Reviews or CADTH Pharmaceutical Reviews Programs —– the CADTH Common Drug Review (CDR) or the CADTH pan-Canadian Oncology Drug Review (pCODR).
You may be eligible to register if you are a:
- member of a pCODR or CAR T-cell patient group
- member of a tumour group
- drug manufacturer or designated consultant
How to Register for CADTH Collaborative Workspaces
Note: It is important to have your registration completed in advance of CADTH Reviews deadlines for submitting information, input, and/or feedback.
|Step 1||Review and confirm that you meet the CDR, pCODR or CAR T-cell registration criteria.|
|Within two business days of submitting your registration request, you will receive an email from CADTH with instructions on the final steps for completing your registration.|
|Complete the steps outlined in the email. Your email address will be your username and you will also be required to create a password. These credentials will then allow you to log in to CADTH’s secure Collaborative Workspaces.|
When you log in as a user, you will be automatically directed to one of four pages based on your profile: manufacturer, tumour group, patient group, or clinician.
If you have any questions about the registration process, please send us an email at firstname.lastname@example.org.